Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRIS
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Margarita Morozova Mikhail Y. Ivanov |
| Publication date | November 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |